RT Book, Section
A1 Berkel, Victor van
A1 Carr, Michael J.
A1 Dunlap, Neal E.
A1 Fox, Matthew
A1 Gil-Bazo, Ignacio
A1 Kumar, Rohit
A1 Marino, Katy Alyse
A1 May, Mike
A1 Ngo, Phuong T.
A1 Pinto-Llerena, Jose
A1 Raez, Luis E.
A1 Rice, Jonathan
A2 Kloecker, Goetz
A2 Arnold, Susanne M.
A2 Fraig, Mostafa M.
A2 Perez, Cesar A.
SR Print(0)
ID 1176019855
T1 Non–Small Cell Lung Cancer Treatment: Early Stage
T2 Lung Cancer: Standards of Care
YR 2021
FD 2021
PB McGraw-Hill
PP New York, NY
SN 9781260136203
LK hemonc.mhmedical.com/content.aspx?aid=1176019855
RD 2024/04/24
AB A  62-year-old  African  American  male  presents  to  his  primary  care  physician  for  routine  health  maintenance.  He  has  diabetes  mellitus  (DM)  controlled  on  oral  medications  and  hypertension  (HTN),  for  which  he  takes  hydrochlorothiazide  and  lisinopril.  He  has  a  50  pack-year  smoking  history,  so  his  physician  orders  low-dose  chest  computed  tomography  (CT),  which  shows  a  2.1-cm  mass  in  the  left  upper  lobe  area.  His  laboratory  work  is  normal.  He  sees  a  pulmonology  and  undergoes  endobronchial  ultrasound  (EBUS)–guided  biopsy,  which  shows  adenocarcinoma.  The  patient  wonders  if  he  will  need  surgery,  radiation,  chemotherapy,  or  all  three.